Development of porcine model of chronic tachycardia-induced cardiomyopathy

Int J Cardiol. 2011 Nov 17;153(1):36-41. doi: 10.1016/j.ijcard.2010.08.033. Epub 2010 Sep 29.

Abstract

Background: There are few experimental models of heart failure (HF) in large animals, despite structural and functional similarities to human myocardium. We have developed a porcine model of chronic tachycardia-induced cardiomyopathy.

Methods: Homogenous siblings of White Large breed swine (n=6) underwent continuous right ventricular (RV) pacing at 170 bpm; 2 subjects served as controls. In the course of RV pacing, animals developed a clinical picture of HF and were presented for euthanasia at subsequent stages: mild, moderate and end-stage HF. Left ventricle (LV) sections were analyzed histologically and relative ANP, BNP, phospholamban and sarcoplasmic reticulum calcium ATPase 2a transcript levels in LV were quantified by real time RT-PCR.

Results: In the course of RV pacing, animals demonstrated reduced exercise capacity (time of running until being dyspnoeic: 6.6 ± 0.5 vs. 2.4 ± 1.4 min), LV dilatation (LVEDD: 4.9 ± 0.4 vs. 6.7 ± 0.4 cm), impaired LV systolic function (LVEF: 69 ± 8 vs. 32 ± 7 %), (all baseline vs. before euthanasia, all p<0.001). LV tissues from animals with moderate and end-stage HF demonstrated local foci of interstitial fibrosis, congestion, cardiomyocyte hypertrophy and atrophy, which was not detected in controls and mild HF animals. The up-regulation of ANP and BNP and a reduction in a ratio of sarcoplasmic reticulum calcium ATPase 2a and phospholamban in failing myocardium were observed as compared to controls.

Conclusions: In pigs, chronic RV pacing at relatively low rate can be used as an experimental model of HF, as it results in a gradual deterioration of exercise tolerance accompanied by myocardial remodeling confirmed at subcellular level.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atrial Natriuretic Factor / biosynthesis
  • Atrial Natriuretic Factor / blood
  • Cardiac Pacing, Artificial / methods
  • Cardiomyopathies / enzymology
  • Cardiomyopathies / etiology*
  • Cardiomyopathies / metabolism*
  • Chronic Disease
  • Disease Models, Animal*
  • Exercise Test / methods
  • Female
  • Natriuretic Peptide, Brain / biosynthesis
  • Natriuretic Peptide, Brain / blood
  • Random Allocation
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / biosynthesis
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / blood
  • Swine
  • Tachycardia / complications*
  • Tachycardia / enzymology
  • Tachycardia / metabolism*

Substances

  • Natriuretic Peptide, Brain
  • Atrial Natriuretic Factor
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases